Availability of asthma quick relief medication in five Alabama school systems

Joe K Gerald, Nancy R Stroupe, Leslie A. McClure, Lani Wheeler, Lynn B Gerald

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. Patients and Methods: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. Results: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. Conclusion: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.

Original languageEnglish (US)
Pages (from-to)11-16
Number of pages6
JournalPediatric, Allergy, Immunology, and Pulmonology
Volume25
Issue number1
DOIs
StatePublished - Mar 1 2012

Fingerprint

Albuterol
Asthma
Students
Patient Acceptance of Health Care
Tobacco Smoke Pollution
Insurance Coverage
Medication Adherence
African Americans
Outcome Assessment (Health Care)
Exercise
Physicians

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Availability of asthma quick relief medication in five Alabama school systems. / Gerald, Joe K; Stroupe, Nancy R; McClure, Leslie A.; Wheeler, Lani; Gerald, Lynn B.

In: Pediatric, Allergy, Immunology, and Pulmonology, Vol. 25, No. 1, 01.03.2012, p. 11-16.

Research output: Contribution to journalArticle

@article{0b10ae3b154c40fb85e0ab8dd3128be5,
title = "Availability of asthma quick relief medication in five Alabama school systems",
abstract = "Objectives: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. Patients and Methods: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. Results: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91{\%} were African American, and 79{\%} had moderate persistent asthma. No student had a complete asthma action plan on file and only 14{\%} had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. Conclusion: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.",
author = "Gerald, {Joe K} and Stroupe, {Nancy R} and McClure, {Leslie A.} and Lani Wheeler and Gerald, {Lynn B}",
year = "2012",
month = "3",
day = "1",
doi = "10.1089/ped.2011.0118",
language = "English (US)",
volume = "25",
pages = "11--16",
journal = "Pediatric, Allergy, Immunology, and Pulmonology",
issn = "2151-321X",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Availability of asthma quick relief medication in five Alabama school systems

AU - Gerald, Joe K

AU - Stroupe, Nancy R

AU - McClure, Leslie A.

AU - Wheeler, Lani

AU - Gerald, Lynn B

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Objectives: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. Patients and Methods: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. Results: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. Conclusion: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.

AB - Objectives: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. Patients and Methods: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. Results: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. Conclusion: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.

UR - http://www.scopus.com/inward/record.url?scp=84858429584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858429584&partnerID=8YFLogxK

U2 - 10.1089/ped.2011.0118

DO - 10.1089/ped.2011.0118

M3 - Article

AN - SCOPUS:84858429584

VL - 25

SP - 11

EP - 16

JO - Pediatric, Allergy, Immunology, and Pulmonology

JF - Pediatric, Allergy, Immunology, and Pulmonology

SN - 2151-321X

IS - 1

ER -